CUSIP 87650L103COMTARSQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
245 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 3.79M | $310.37M | +10.9K | Added |
| 2 | Rtw Investments, LP | 3.34M | $273.10M | +157.9K | Added |
| 3 | Deep Track Capital, LP | 3.00M | $245.97M | +4.0K | Added |
| 4 | Paradigm Biocapital Advisors LP | 2.56M | $209.79M |
| −103.5K |
| Reduced |
| 5 | Vanguard Group Inc | 2.40M | $196.48M | +127.5K | Added |
| 6 | Jennison Associates LLC | 2.23M | $182.60M | −374.5K | Reduced |
| 7 | Morgan Stanley | 2.04M | $167.10M | +128.3K | Added |
| 8 | Janus Henderson Group PLC | 1.93M | $158.06M | +491.3K | Added |
| 9 | Tang Capital Management LLC | 1.19M | $97.32M | −1.27M | Reduced |
| 10 | Driehaus Capital Management LLC | 1.17M | $96.00M | +141.4K | Added |
See every fund holding Tarsus Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders